Compare OGI & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGI | FLC |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.5M | 181.5M |
| IPO Year | N/A | N/A |
| Metric | OGI | FLC |
|---|---|---|
| Price | $1.62 | $17.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 37.8K |
| Earning Date | 02-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.64% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $186,075,713.00 | N/A |
| Revenue This Year | $20.38 | N/A |
| Revenue Next Year | $6.02 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.85 | $12.62 |
| 52 Week High | $2.24 | $15.45 |
| Indicator | OGI | FLC |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 59.19 |
| Support Level | $1.28 | $17.42 |
| Resistance Level | $1.77 | $17.71 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 61.54 | 80.00 |
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.